Radical-induced lipoprotein and plasma lipid oxidation in normal and apolipoprotein E gene knockout (apoE(-/-)) mice: ApoE(-/-) mouse as a model for testing the role of tocopherol-mediated peroxidation in atherogenesis

Journal of Lipid Research

Volumn 39, Issue 2, 1998, Pages 354-368

  Neužil, Jiří ^a   Christison, Julie K ^a   Iheanacho, Eugene ^b   Fragonas, Jean Charles ^b   Zammit, Vivienne ^a   Hunt, Nicholas H ^b   Stocker, Roland ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antioxidants; Atherosclerosis; Lipid peroxidation; Vitamin E

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN E; LIPOPROTEIN; RADICAL; TOCOPHEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENDOTHELIUM CELL; FOAM CELL; GENETIC SUSCEPTIBILITY; KNOCKOUT MOUSE; LIPID BLOOD LEVEL; LIPID OXIDATION; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; ASCORBIC ACID; CHOLESTEROL ESTERS; HUMANS; KINETICS; LIPID PEROXIDATION; LIPOPROTEINS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; PEROXIDES; URIC ACID; VITAMIN E;

EID: 0031887228     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
2. Witztum, J. L. 1994. The oxidation hypothesis of atherosclerosis. Lancet. 344: 793-795.
3. Berliner, J. A., and J. W. Heinecke. 1996. The role of oxidized lipoproteins in atherogenesis. Free Radical Biol. Med. 20: 707-727.
4. Kuhn, H., J. Belkner, S. Zaiss, T. Fahrenklemper, and S. Wohlfeil. 1994. Involvement of 15-lipoxygenase in early stages of atherogenesis. J. Exp. Med. 179: 1903-1911.
5. Daugherty, A., J. L. Dunn, D. L. Rateri, and J. W. Heinecke. 1994. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94: 437-444.
6. Hazell, L. J., L. Arnold, D. Flowers, G. Waeg, E. Malle, and R. Stocker. 1996. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97: 1535-1544.
7. White, C. R., T. A. Brock, L. V. Chang, J. Crapo, P. Briscoe, D. Ku, W. A. Bradley, S. H. Gianturco, J. Gore, B. A. Freeman, and M. M. Tarpey. 1994. Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Sci. USA. 91: 1044-1048.
8. Heinecke, J. W., H. Rosen, and A. Chait. 1984. Iron and copper promote modification of low density lipoprotein in vitro by free radical oxidation. J. Clin. Invest. 74: 1890-1894.
9. Balla, G., H. S. Jacob, J. W. Eaton, J. D. Belcher, and G. M. Vercellotti. 1991. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler. Thromb. 11: 1700-1711.
10. Ehrenwald, E., and P. L. Fox. 1996. Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells. J. Clin. Invest. 97: 884-890.
11. Esterbauer, H., J. Gebicki, H. Puhl, and G. Jürgens. 1992. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Frer Radical Biol. Med. 13: 341-390.
12. Carew, T. E., D. C. Schwenke, and D. Steinberg. 1987. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis: the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. USA. 84: 7725-7729.
13. Kita, T., Y. Nagano, M. Yokode, K. Ishii, N. Kume, A. Ooshima, H. Yoshida, and C. Kawai. 1987. Probucol prevents the progression of atheroslcerosis in Watanabe heritable hvperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 84: 5928-5931.
14. Sparrow, C. P., T. W. Doebber, J. Olszewski, M. S. Wu, J. Ventre, K. A. Stevens, and Y. S. Chao. 1992. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenyl-phenylenediamine. J. Clin. Invest. 89: 1885-1891.
15. Fruebis, J., D. Steinberg, H. A. Dresel, and T. A. Carew. 1994. A comparison of the antiatherogenic effects of probucol and a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits. J. Clin. Invest. 94: 392-398.
16. Steinbrecher, U. P., M. Lougheed, W-C. Kwan, and M. Dirks. 1989. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. J. Biol. Chem. 264: 15216-15223.
17. Bowry, V. W., and R. Stocker. 1993. Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J. Am. Chem. Soc. 115: 6029-6044.
18. Neužil, J., S. R. Thomas, and R. Stocker. 1997. Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free Radical Biol. Med. 22: 57-71.
19. Kontush, A., B. Finckh, B. Karten, A. Kohlschütter, and L. Beisiegel. 1996. Antioxidant and prooxidant activity of α-tocopherol in human plasma and low density lipoprotein. J. Lipid Res. 37: 1436-1448.
20. Neužil, J., and R. Stocker. 1994. Free and albumin-bound bilirubin is an efficient co-antioxidant for α-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J. Biol. Chem. 269: 16712-16719.
21. Stocker, R. 1994. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinic relevance. Curr. Opin. Lipidol. 5: 422-433.
22. Bowry, V. W., D. Mohr, J. Cleary, and R. Stocker. 1995. Prevention of tocopherol-mediated peroxidation of ubiquinol-10-free human low density lipoprotein. J. Biol. Chem. 270: 5756-5763.
23. Witting, P. K., C. Westerlund, and R. Stocker 1996. A rapid and simple screening test for potential inhibitors of tocopherol-mediated peroxidation of LDL lipids. J. Lipid Res. 37: 853-867.
24. Frei, B., R. Stocker, and B. N. Ames. 1988. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc. Natl. Acad. Sci. USA. 85: 9748-9752.
25. Dabbagh, A. J., and B. Frei. 1995. Human suction blister interstitial fluid prevents metal ion-dependent oxidation of low density lipoprotein by macrophages and in cell-free systems. J. Clin. Invest. 96: 1958-1966.
26. Suarna, C., R. T. Dean, J. May, and R. Stocker. 1995. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate. Arterioscler. Thromb. Vasc. Biol. 15: 1616-1624.
27. Plump, A. S., J. D. Smith, T. Hayek, K. Aalto-Setälä, A. Walsh, J. G. Verstuyft, E. M. Rubin, and J. L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination on ES cells. Cell. 71: 343-353.
28. Zhan, S. H., R. L. Reddick, J. A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258: 468-471.
29. Nakashima, Y., A. S. Plump, E. W. Raines, J. L. Breslow, and R. Ross. 1993. ApoE-deficient mice develop lesions of all phases of artherosclerosis throughout the arterial tree. Arterioscler. Thomb. 14: 133-140.
30. Zhou, X., S. Stemme, and G. K. Hansson. 1996. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein E-deficient mice. Am. J. Pathol. 149: 359-366.
31. Lichtman, A. H., M. Cybulsky, and F. W. Luscinskas. 1996. Immunology of atherosclerosis: the promise of mouse models. Am. J. Pathol. 149: 351-357.
32. Hayek, T., J. Oiknine, J. G. Brook, and M. Aviram. 1994. Increased plasma and lipoprotein lipid peroxidation in apoE-deficient mice. Bioehem. Biophys. Res. Commun. 201: 1567-1574.
33. Palinski, W., S. Horkko, E. Miller, U. P. Steinbrecher, H. C. Powell, L. K. Curtiss, and J. L. Witztum, 1996. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest. 98: 800-814.
34. Tangirala, R. K., F. Casanada, E. Miller, J. L. Witztum, D. Steinberg, and W. Palinski. 1995. Effect of the antioxidant N,N′-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 15: 1625-1630.
35. Sattler, W., D. Mohr, and R. Stocker. 1994. Rapid isolation of lipoproteins and assessment of their peroxidation by HPLC postcolumn chemiluminescence. Methods Enzymol. 233: 469-489.
36. Barclay, L. R. C., S. J. Locke, J. M. MacNeil, and J. VanKessel. 1984. Autoxidation of micelles and model membranes. Quantitative kinetic measurements can be made by using either water-soluble or lipid-soluble initiators with water-soluble or lipid-soluble chain-breaking antioxidants. J. Am. Chem. Soc. 106: 2479-2481.
37. Niki, E., M. Saito, Y. Yoshikawa, Y. Yamamoto, and Y. Kamiya. 1986. Oxidation of lipids. XII. Inhibition of oxidation of soybean phosphatidylcholine and methyl linoleate in aqueous dispersion by uric acid. Bull. Chem. Soc. Jpn. 59: 471-477.
38. Kritharides, L., W. Jessup, J. Gifford, and R. T. Dean. 1993. A method for defining the stages of LDL oxidation by the separation of cholesterol and cholesteryl ester oxidation products by HPLC. Anal. Biochem. 213: 79-89.
39. Pascoe, G. A., C. T. Duda, and D. J. Reed. 1987. Determination of α-tocopherol and α-tocopherylquinone in small biological samples by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 414: 440-448.
40. Behrens, W. A., and R. Madere. 1987. A highly sensitive high-performance liquid chromatography method for the estimation of ascorbic and dehydroascorbic acid in tissues, biological fluids, and foods. Anal. Biochem. 165: 102-107.
41. Warnick, G. R., M. C. Cheung, and J. J. Albers. 1979. Comparison of current methods for high-density lipoprotein cholesterol quantitation. Clin. Chem. 25: 596-604.
42. Hunt, N. H., M. Kopp, and R. Stocker. 1992. Free radicals and antioxidants in malaria. In Lipid-soluble Antioxidants: Biochemistry and Clinical Applications. Y Chong and L. Packer, editors. Birkhäuser Publishers, Basel. 337-354.
43. Sattler, W., J. K. Christison, and R. Stocker. 1995. Cholesteryl ester hydroperoxide reducing activity associated with isolated highand low-density lipoproteins. Free Radical Biol. Med. 18: 421-429.
44. Piedrahita, J. A., S. H. Zhang, J. R. Hagaman, P. M. Oliver, and N. Maeda. 1992. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89: 4471-4475.
45. Palinski, W., V. A. Ord, A. S. Plump, J. L. Breslow, D. Steinberg, and J. L. Witztum. 1994. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titres of autoantibodies to malondialdehydelysine in serum. Arterioscler. Thromb. 14: 605-616.
46. Bowry, V. W., K. U. Ingold, and R. Stocker. 1992. Vitamin E in human low-density lipoprotein. When and how this anti-oxidant becomes a pro-oxidant. Biochem. J. 288: 341-344.
47. Breslow, J. L. 1996. Mouse models of atherosclerosis. Science. 272: 685-688.
48. Gordon, D. J., and B. M. Rifkind. 1989. High-density lipoprotein - the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.
49. Mohr, D., and R. Stocker. 1994. Radical-mediated oxidation of isolated human very low density lipoprotein. Arterioscler. Thromb. 14: 1186-1192.
50. Plump, A. S., C. J. Scott, and J. L. Breslow. 1994. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA. 91: 9607-9611.
51. Reddick, R. L., S. H. Zhang, and N. Maeda. 1994. Atherosclerosis in mice lacking apoE. Arterioscler. Thromb. 14: 141-147.
52. Upston, J. M., J. Neužil, and R. Stocker. 1996. Oxidation of LDL by recombinant human 15-lipoxygenase: evidence for α-tocopherol dependent oxidation of esterified core and surface lipids. J. Lipid Res. 37: 2650-2661.
53. Thomas, S. R., J. Neužil, and R. Stocker. 1996. Co-supplementation with coenzyme Q prevents the pro-oxidant effect of α-tocopherol and increases the resistance of low-density lipoprotein towards transition metal-dependent oxidation initiation. Arterioscler. Thromb. Vasc. Biol. 16: 687-696.
54. Witting, P. K., J. M. Upston, and R. Stocker. 1997. The role of α-tocopheroxyl radical in the initiation of lipid peroxidation in human low density lipoprotein exposed to horse radish peroxidase. Biochemistry. 36: 1251-1258.
55. Jessup, W., D. Mohr, S. P. Gieseg, R. T. Dean, and R. Stocker. 1992. The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low-density lipoprotein. Biochim. Biophys. Acta. 1180: 73-82.
56. Hazell, L. J., and R. Stocker. 1993. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem. J. 290: 165-172.
57. Smith, J. D., E. Trogan, M. Ginsberg, C. Grigaux, J. Tian, and M. Miyata. 1995. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. USA. 92: 8264-8268.